6th Obesity & NASH Drug Development Summit
29
Nov
-
01
Dec
2022
When
Boston
Massachusetts
USA
Where

Welcome to the 6th Obesity & NASH Drug Development Summit There has been a rise and fall of investment in NASH in the wake of highly demanding biopsy endpoints and late-stage clinical setbacks.

Similar Events

You May Like

Event

Hanson Wade

0/5
(0)

Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.

29 - 01 Dec 2022
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Director, Translational Medicine Cardiometabolic Disease
Executive Director, Biomarker Science
SVP, NonClinical R&D and Chemistry
Founder, CEO & Board Member
Chief Scientific Officer
Chief Medical Officer
Chief Executive Officer
Executive Director
EVP and Chief Development Officer
Chief Development Officer

Sponsors and Exhibitors
Brand, Media and Promotional Partners

ICON plc

ICON plc is a global provider of outsourced drug development and commercialisation solutions and services to pharmaceutical, biotechnology, medical device, and government and public health organisations.

Antaros Medical

Visualizing the Future – Minimizing risk Antaros Medical is an entirely unique service provider. We are pioneering new frontiers in innovative MRI/PET imaging techniques, seamless clinical drug development and understanding of human pathophysiology.

Nordic Bioscience A/S

Nordic Bioscience is the leading expert in extracellular matrix (ECM) research with 25+ years of experience in biomarker development, pre-clinical and clinical research.

OM1, Inc.

OM1 is a leading health outcomes and registries company focused on the measurement, comparison, and prediction of treatment outcomes.

Physiogenex

Physiogenex is a leading preclinical contract research organization (CRO) specializing in metabolic disorders such as diabetes, obesity, liver diseases, dyslipidemia, atherosclerosis and cardiovascular complications.

Cerba Research

Cerba Research is the merge of Barc Lab, Histalim and Cerba Xpert. All 3 entities are part of the Cerba HealthCare group and have decided to join forces under one name.

Fibrofind LTD

FibroFind is a rapidly developing biomedical sciences company that has a deep understanding of fibrosis biology and has employed this knowledge to design bespoke biological assays with human tissues that can determine if a novel drug is able to preve

Perspectum Ltd

Perspectum's imaging solutions are safe, fast, and can offer more comprehensive diagnostics. We help doctors understand complex data and help deliver precision care to more patients. We believe the voice of the.

HepQuant

HepQuant is a privately-held, early-stage medical diagnostics company with unique, patented and patent-pending technology for assessing liver function of patients with chronic liver disease.

Organizer

Get emails from us

Thank you
Oops! Something went wrong